Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Net Margin (2022 - 2025)

Gossamer Bio's Net Margin history spans 4 years, with the latest figure at 342.33% for Q4 2025.

  • For Q4 2025, Net Margin rose 986.0% year-over-year to 342.33%; the TTM value through Dec 2025 reached 356.9%, down 30519.0%, while the annual FY2025 figure was 351.49%, 30221.0% down from the prior year.
  • Net Margin reached 342.33% in Q4 2025 per GOSS's latest filing, up from 362.73% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 1698.73% in Q3 2022 to a low of 397.03% in Q1 2025.
  • Average Net Margin over 4 years is 503.83%, with a median of 136.76% recorded in 2024.
  • The largest YoY upside for Net Margin was 986bps in 2025 against a maximum downside of -38453bps in 2025.
  • A 4-year view of Net Margin shows it stood at 1655.19% in 2022, then dropped by -12bps to 1453.0% in 2023, then tumbled by -124bps to 352.19% in 2024, then grew by 3bps to 342.33% in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Net Margin are 342.33% (Q4 2025), 362.73% (Q3 2025), and 333.13% (Q2 2025).